
### [NCIT:C7653](http://purl.obolibrary.org/obo/NCIT_C7653)
**Label:** Intermediate Soft Tissue Tumor

**Subclasses:** [NCIT:C6814](http://purl.obolibrary.org/obo/NCIT_C6814) (Superficial Fibromatosis), [NCIT:C3741](http://purl.obolibrary.org/obo/NCIT_C3741) (Abdominal (Mesenteric) Fibromatosis), [NCIT:C7344](http://purl.obolibrary.org/obo/NCIT_C7344) (Intermediate Cutaneous Fibrohistiocytic Neoplasm), [NCIT:C99180](http://purl.obolibrary.org/obo/NCIT_C99180) (Lipofibromatosis), [NCIT:C6177](http://purl.obolibrary.org/obo/NCIT_C6177) (Bladder Inflammatory Myofibroblastic Tumor), [NCIT:C7020](http://purl.obolibrary.org/obo/NCIT_C7020) (Central Nervous System Inflammatory Myofibroblastic Tumor), [NCIT:C7022](http://purl.obolibrary.org/obo/NCIT_C7022) (Gastric Inflammatory Myofibroblastic Tumor), [NCIT:C6494](http://purl.obolibrary.org/obo/NCIT_C6494) (Angiomatoid Fibrous Histiocytoma), [NCIT:C7391](http://purl.obolibrary.org/obo/NCIT_C7391) (Intermediate Blood Vessel Neoplasm), [NCIT:C38106](http://purl.obolibrary.org/obo/NCIT_C38106) (Myxoid Dermatofibrosarcoma Protuberans), [NCIT:C38107](http://purl.obolibrary.org/obo/NCIT_C38107) (Dedifferentiated Dermatofibrosarcoma Protuberans), [NCIT:C6505](http://purl.obolibrary.org/obo/NCIT_C6505) (Atypical Lipomatous Tumor), [NCIT:C5978](http://purl.obolibrary.org/obo/NCIT_C5978) (Benign Salivary Gland Myoepithelioma), [NCIT:C5858](http://purl.obolibrary.org/obo/NCIT_C5858) (Liver Inflammatory Myofibroblastic Tumor), [NCIT:C3316](http://purl.obolibrary.org/obo/NCIT_C3316) (Penile Fibromatosis), [NCIT:C4246](http://purl.obolibrary.org/obo/NCIT_C4246) (Atypical Fibroxanthoma), [NCIT:C54000](http://purl.obolibrary.org/obo/NCIT_C54000) (Gastrointestinal Stromal Tumor of Uncertain Malignant Potential), [NCIT:C7630](http://purl.obolibrary.org/obo/NCIT_C7630) (Intermediate Lipomatous Neoplasm), [NCIT:C4683](http://purl.obolibrary.org/obo/NCIT_C4683) (Dermatofibrosarcoma Protuberans), [NCIT:C4680](http://purl.obolibrary.org/obo/NCIT_C4680) (Plantar Fibromatosis), [NCIT:C39740](http://purl.obolibrary.org/obo/NCIT_C39740) (Lung Inflammatory Myofibroblastic Tumor), [NCIT:C39741](http://purl.obolibrary.org/obo/NCIT_C39741) (Retroperitoneal Inflammatory Myofibroblastic Tumor), [NCIT:C40177](http://purl.obolibrary.org/obo/NCIT_C40177) (Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential), [NCIT:C9182](http://purl.obolibrary.org/obo/NCIT_C9182) (Desmoid-Type Fibromatosis), [NCIT:C39905](http://purl.obolibrary.org/obo/NCIT_C39905) (Prostate Stromal Proliferation of Uncertain Malignant Potential), [NCIT:C27511](http://purl.obolibrary.org/obo/NCIT_C27511) (Retiform Hemangioendothelioma), [NCIT:C27510](http://purl.obolibrary.org/obo/NCIT_C27510) (Kaposiform Hemangioendothelioma), [NCIT:C7526](http://purl.obolibrary.org/obo/NCIT_C7526) (Papillary Intralymphatic Angioendothelioma), [NCIT:C49107](http://purl.obolibrary.org/obo/NCIT_C49107) (Giant Cell Tumor of Soft Tissue), [NCIT:C7442](http://purl.obolibrary.org/obo/NCIT_C7442) (Benign Myoepithelioma), [NCIT:C121738](http://purl.obolibrary.org/obo/NCIT_C121738) (Intermediate Soft Tissue Tumor of Uncertain Differentiation), [NCIT:C4700](http://purl.obolibrary.org/obo/NCIT_C4700) (Giant Cell Fibroblastoma), [NCIT:C6489](http://purl.obolibrary.org/obo/NCIT_C6489) (Extraabdominal Fibromatosis), [NCIT:C45474](http://purl.obolibrary.org/obo/NCIT_C45474) (Intermediate (Rarely Metastasizing) Blood Vessel Neoplasm), [NCIT:C45473](http://purl.obolibrary.org/obo/NCIT_C45473) (Intermediate (Locally Aggressive) Blood Vessel Neoplasm), [NCIT:C45476](http://purl.obolibrary.org/obo/NCIT_C45476) (Polymorphus Hemangioendothelioma), [NCIT:C7333](http://purl.obolibrary.org/obo/NCIT_C7333) (Intermediate Fibroblastic Neoplasm), [NCIT:C45475](http://purl.obolibrary.org/obo/NCIT_C45475) (Composite Hemangioendothelioma), [NCIT:C45753](http://purl.obolibrary.org/obo/NCIT_C45753) (Cardiac Inflammatory Myofibroblastic Tumor), [NCIT:C121668](http://purl.obolibrary.org/obo/NCIT_C121668) (Pseudomyogenic Hemangioendothelioma), [NCIT:C7334](http://purl.obolibrary.org/obo/NCIT_C7334) (Intermediate Vascular Neoplasm), [NCIT:C27546](http://purl.obolibrary.org/obo/NCIT_C27546) (Spindle Cell Type Atypical Fibroxanthoma), [NCIT:C27545](http://purl.obolibrary.org/obo/NCIT_C27545) (Classic Type Atypical Fibroxanthoma), [NCIT:C6481](http://purl.obolibrary.org/obo/NCIT_C6481) (Inflammatory Myofibroblastic Tumor), [NCIT:C6491](http://purl.obolibrary.org/obo/NCIT_C6491) (Intermediate Fibrohistiocytic Neoplasm), [NCIT:C40398](http://purl.obolibrary.org/obo/NCIT_C40398) (Breast Inflammatory Myofibroblastic Tumor), [NCIT:C129548](http://purl.obolibrary.org/obo/NCIT_C129548) (Central Nervous System Desmoid-Type Fibromatosis), [NCIT:C95898](http://purl.obolibrary.org/obo/NCIT_C95898) (Gastric Gastrointestinal Stromal Tumor of Uncertain Malignant Potential), [NCIT:C121786](http://purl.obolibrary.org/obo/NCIT_C121786) (Mixed Tumor, Not Otherwise Specified), [NCIT:C126359](http://purl.obolibrary.org/obo/NCIT_C126359) (Abdominal Inflammatory Myofibroblastic Tumor), [NCIT:C126358](http://purl.obolibrary.org/obo/NCIT_C126358) (Pelvic Fibromatosis), 

**Class expressions from DL-Learner:**

- [NCIT:C53415](http://purl.obolibrary.org/obo/NCIT_C53415) (Locally Aggressive Lesion) 66.67%
- Thing 51.39%
- [NCIT:C12471](http://purl.obolibrary.org/obo/NCIT_C12471) (Soft Tissue) 45.53%
- [NCIT:C12964](http://purl.obolibrary.org/obo/NCIT_C12964) (Connective and Soft Tissue) 39.03%
- [NCIT:C3824](http://purl.obolibrary.org/obo/NCIT_C3824) (Lesion) 22.97%
- [UBERON:0000479](http://purl.obolibrary.org/obo/UBERON_0000479) (tissue) 20.28%
- [NCIT:C12922](http://purl.obolibrary.org/obo/NCIT_C12922) (Neoplastic Cell) 19.15%
- [NCIT:C12913](http://purl.obolibrary.org/obo/NCIT_C12913) (Abnormal Cell) 19.03%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 18.46%
- [UBERON:0010000](http://purl.obolibrary.org/obo/UBERON_0010000) (multicellular anatomical structure) 18.40%
- [UBERON:0000061](http://purl.obolibrary.org/obo/UBERON_0000061) (anatomical structure) 18.34%
- [UBERON:0000465](http://purl.obolibrary.org/obo/UBERON_0000465) (material anatomical entity) 18.28%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 18.19%
- [BFO:0000040](http://purl.obolibrary.org/obo/BFO_0000040) (material entity) 18.19%
- [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 18.18%


